Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Morning SOG. Below link details US patent application made by Sierra in relation to SRA737 and Parpi
https://patents.justia.com/patent/20210077499
ref the named inventors as follows:
Inventor John Charles Reader, Jamie Conor MARSHALL, John Mykytiuk, Julian Scott Northen
Jamie Conor Marhsall: Senior Solid State Scientist at Sterling Pharma Solutions
John Mykytiuk : Solid State Manager Sterling Pharma Solutions - Uiversity of Bradford
Julian Scott Northern - Onyx Scientific (current position may well have been previously been with Sterling)
Published March 2020 but still a very encouraging read.
“Combined treatment with SRA737 and an experimental inhibitor of B-family DNA polymerases called aphidicolin stripped cancer cells of their ability to cope with DNA damage, and was more effective at killing them in eight of the nine cancer cell lines tested.”
https://www.icr.ac.uk/news-archive/two-pronged-attack-on-dna-repair-could-kill-drug-resistant-cancers
Interesting read
https://www.nature.com/articles/d41586-022-01613-2
It’s a dog share no one wants it. Going no where, pointless purchase etc etc etc……..
That’s why your on here moaning about it…. You claim to be invested in it…..
What bit makes sense????
Mummy why didn’t you show me more love? If you had I wouldn’t have to go on the BB and try to annoy people with my negativity.
If you don’t like the performance, just sell up and move on.
Bluenose - celtic said “This is getting further investigated by GSK , 100 percent convinced.” Why do you think this is not factual correct. I assume you accept GSK would do extensive due diligence. Would they not investigate ever aspect of their proposed purchase?
Bluenose, have a look at the following GSK press release ref planned purchase of Sierra
https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-sierra-oncology-for-19bn/
You will see the following para:
“Sierra Oncology is a late-stage biopharmaceutical company based in San Mateo, California, on a mission to deliver targeted therapies that treat rare forms of cancer. In addition to momelotinib, the pipeline consists of two assets in phase I SRA515 and SRA737. SRA515 is a selective bromodomain-containing protein 4 (BRD4) bromodomain and extra-terminal domain (BET) inhibitor with a novel bivalent binding mode that inhibits both protein bromodomains, and SRA737 is a novel checkpoint kinase 1 (CHK1) inhibitor.”
Note they refer to SRA737 as an asset.
Ask yourself this question? What is an asset?
According to the Oxford dictionary “an item of property owned by a person or company, regarded as having value and available to meet debts, commitments, or legacies.”
They have already confirmed it has value, so what do you think they will do with it?
Colbaltblue, or is it Capt "blame everyone else for my own decisions". Might I suggest you grow a pair of wings and move into bingo. It too is a form of gambling, clearly playing the markets is not for you sweet pea.
Yes, it says the MM's are happy to buy them as they know they will sell them on. Stop dripping its boring.
What you should have done is bought a 10 million sub 0.5p, sold them at 9p and then got back in when the price dropped back.